Investment thesis
Interactive widgets visualize the load-bearing thesis claims. Drill into each via the linked source pages.
Customer pipeline
Stage 1
Exploratory
>10
Material samples, NDA-bounded conversations
Stage 2
Sample / NRE
5-10
Engineering sample shipments, joint design work
Stage 3
Qualified design-in
4
4 unnamed Fortune 500 customers in pre-production qualification (LWLG-disclosed)
Stage 4
Commercial production
0
Target H1 2027 — single most catalytic disclosure
Stage-3 customer pipeline
#1 1.6T Transceiver customer slot #1
disclosed: Nov 4, 2025
stage: Stage 3 — chips Q2 2026
Candidate companies
InnoLight Coherent Intel ★ Cisco ★ Broadcom ★ Marvell ★
Bear
Drops out / chips fail
Base
Converts to Stage 4 H1 2027
Bull
Production Q1 2027
#2 CPO Materials customer slot #2
disclosed: Nov 25, 2025
stage: Stage 3 — PDK H1 2026
Candidate companies
Intel ★ Broadcom ★ Marvell ★ NVIDIA
Bear
Slips to 2028+
Base
PDK lands, sampling 2027
Bull
CPO design win Q4 2027
#3 Embedded Mods customer slot #3
disclosed: 2025
stage: Stage 3 — first EO at SOTA fab
Candidate companies
Intel ★ Cisco ★ Broadcom ★
Bear
No production this decade
Base
Sampling 2027
Bull
Production 2028
#4 Internal SiPh customer slot #4
disclosed: Feb 24, 2026
stage: Stage 3 — hyperscale DC
Candidate companies
Intel ★ Cisco ★ Broadcom ★ Google ★ Microsoft ★ Meta ★
Bear
Internal effort cancelled
Base
Hyperscaler pilot 2027
Bull
Volume H2 2027
★ analyst-speculated Stage-3 candidate (not company-confirmed)
Patent expiry waterfall
The "2029 cliff" framing weakens once continuation chains are factored in: protection runs to ~2042 in the cladding-stack family.
20242030203520402045
US 7,919,619 Goetz sister patent
2025-10-26
US 8,269,004 Foundational chromophore (originally framed as 2029 cliff)
2029-03-08
US 11,506,918 ALD encapsulation (4th generation; OTR 1.4×10⁻⁶)
~2040
US 11,661,428 → 12,043,628 → 12,286,438 Thiophene-bridge chain
~2038-10-03
US 11,921,401 + 5 active Diamondoid family (5 active continuations)
~2040
US 11,976,232 → 12,173,217 Tetrahydrocarbazole / lyotropic poling
~2041
US 11,927,868 → 12,547,041 Cladding-stack (broadest stack-level claim)
~2042
● Foundational ·
● Continuation chain ·
● Expired
Source: Patent landscape · 564-line analyst-grade IP analysis
Valuation sensitivity
Sensitivity grid: 2030 mcap = TAM × capture % × royalty % × multiple. NPV-discounted to 2026 at 12%.
TAM held constant at $24B (Jan 2026 deck). Multiple = 12× operating income at 30% op margin (UDC analog).
10
% of $24B 2028 TAM that LWLG captures
5
% of modulator ASP captured by LWLG
2030 revenue
$1.2B
2030 mcap (12× op-inc)
$4.3B
2030 $/share (158.8M FD)
NPV → 2026 (@ 12%)
$17.27
At $12.67 close (Apr 24 2026), the implied 36% upside reflects the bull-base mid-case. Adjust sliders to test bear / bull scenarios.
Source: valuation_model · 4-scenario sensitivity grid · probability-weighted FV ~$32
Drill-down pages
Bull case →
Five-pillar thesis: foundry-PDK lock-in · reliability gate cleared · pipeline filling · Marvell-Polariton validation · cap-table can wait
Bear case →
Five-pillar thesis: TFLN winning the volume window · "nearly there" since 2014 · materials-licensing unproven at scale · persistent dilution · sentiment priced in
Risk register →
Technical · customer · foundry · capital · IP · competitive · market
Catalyst calendar →
Q2 2026 → 2029 · earnings, foundry tape-outs, customer reveals, IP cliffs
Open questions →
What this KB does not yet resolve · research paths for each
NVDA-LWLG validation →
Validation matrix for the NVDA-LWLG timeline DD